Vaxcyte (PCVX) Times Interest Earned (2019 - 2026)
Vaxcyte's (PCVX) quarterly Times Interest Earned came in at -$93.3 in Q1 2026, down 59.15% year-on-year from -$228.37 in Q1 2025, and down 4333.85% on a QoQ basis from -$2.1 in Q4 2025.
Vaxcyte (PCVX) Times Interest Earned (2019 - 2026) Analysis & Trends
Vaxcyte (PCVX) has 8 years of Times Interest Earned data on file, last reported at -$93.3 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 59.15% year-over-year to -$93.3 in Q1 2026; TTM through Mar 2026 was $231.69, a 212.37% increase from a year earlier, with the FY2025 full-year figure at -$1.43, down 12.11% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$93.3, down from -$2.1 in the prior quarter.
- Over the last five years, Times Interest Earned for PCVX reached as high as $19.29 in Q4 2024 and fell as low as -$93.3 in Q1 2026.
- Historically, Times Interest Earned has averaged -$14.2 across 5 years, with a median of -$0.79 in 2022.
- On a YoY basis, Times Interest Earned climbed as much as 94.7% in 2025 and fell as far as 18496.2% in 2025.
- Year by year, Times Interest Earned stood at -$0.79 in 2022, then surged by 42.53% to -$0.45 in 2023, then jumped by 4348.62% to $19.29 in 2024, then slumped by 110.91% to -$2.1 in 2025, then plunged by 4333.85% to -$93.3 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$93.3 in Q1 2026, -$2.1 in Q4 2025, and -$2.05 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Vaxcyte | 7.76 Bn | 7.76 Bn | - | -93.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.30 |
| Dec 31, 2025 | -2.10 |
| Sep 30, 2025 | -2.05 |
| Jun 30, 2025 | -1.87 |
| Mar 31, 2025 | -58.62 |
| Dec 31, 2024 | 19.29 |
| Sep 30, 2024 | -38.72 |
| Jun 30, 2024 | -32.01 |
| Mar 31, 2024 | -0.32 |
| Sep 30, 2023 | -0.45 |
| Jun 30, 2023 | -0.36 |
| Mar 31, 2023 | -0.48 |
| Sep 30, 2022 | -0.79 |
| Jun 30, 2022 | -0.73 |
| Mar 31, 2022 | -0.50 |
| Sep 30, 2021 | -0.29 |
| Mar 31, 2021 | -0.32 |
| Sep 30, 2020 | -0.09 |
| Jun 30, 2020 | -0.15 |
| Mar 31, 2020 | -3,942.29 |